Moreover, the present study is the first to indicate a potential role for ABCG4 expression as an independent predictive factor of poor prognosis in NSCLC patients treated with cisplatin-based combination chemotherapy. This evidence concerns the gene ABCG4 and non-small cell lung carcinoma.